Ardelyx, Inc. insider trading
Every open-market purchase and sale by Ardelyx, Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Ardelyx, Inc.’s insiders pay?
From December 29, 2014 to August 25, 2026, 27 insiders reported 27 open-market purchases and 144 sales not made under a pre-set plan in Ardelyx, Inc. Twelve months after each purchase was reported, the shares were −27.6% against the S&P 500 on average (median −40.9%), over 18 purchases with a full year of prices; 33% beat the index. After sales, the shares moved −49.1% against the index over 12 months (a negative figure means selling was the right call). That rests on fewer than 20 purchases, too few to read much into. Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on June 9, 2015 into $496 by November 2, 2026, −23.2% a year. It held shares 47% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $28,935 (+9.8% a year), and held throughout $43,848 (+13.9%).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Raab Michael | President & CEO | 0 | — | — | 23 | −54.2% (9) | August 25, 2026 |
| Rosenbaum David P. | Chief Development Officer | 0 | — | — | 22 | −55.7% (13) | November 22, 2024 |
| Mott David M | Director | 16 | −28.2% (8) | 38% | 0 | — | February 23, 2026 |
| Williams Laura A | Chief Patient Officer | 0 | — | — | 15 | −34.7% (7) | August 25, 2026 |
| Grammer Elizabeth A | See Remarks | 0 | — | — | 13 | −46.3% (8) | November 25, 2025 |
| Renz Justin A | Chief Financial Officer | 0 | — | — | 13 | −42.6% (7) | August 25, 2025 |
| Blanks Robert | See Remarks | 0 | — | — | 10 | −49.9% (5) | November 22, 2024 |
| Rodriguez Susan | Chief Commercial Officer | 0 | — | — | 8 | −75.0% (3) | May 23, 2024 |
| Foster Eric Duane | Chief Commercial Officer | 0 | — | — | 6 | −59.2% (1) | August 25, 2026 |
| Kelliher Mike | Chief Business Officer | 0 | — | — | 6 | −60.3% (1) | August 25, 2026 |
| Barrett M James and related entities | 10% owner | 3 | −33.6% (3) | 33% | 1 | −0.3% (1) | July 20, 2016 |
| Barris Peter J and related entities | 10% owner | 3 | −33.6% (3) | 33% | 1 | −0.3% (1) | July 20, 2016 |
| Felsch Robert Ora | See Remarks | 0 | — | — | 4 | −51.0% (4) | August 22, 2024 |
| Reilly Joseph James | See Remarks | 0 | — | — | 4 | — | August 25, 2026 |
| Bishop John E | See Remarks | 0 | — | — | 3 | — | August 25, 2026 |
| Brady James Parker | Chief Human Resources Officer | 0 | — | — | 3 | — | August 25, 2026 |
| Ringold Gordon | Director | 3 | +6.4% (2) | 50% | 0 | — | June 1, 2018 |
| Caldwell Jeremy S | EVP, Chief Scientific Officer | 0 | — | — | 2 | −80.9% (2) | March 3, 2017 |
| Kaufmann Mark | Chief Financial Officer | 0 | — | — | 2 | — | January 4, 2019 |
| Presidio Partners 2007 (parallel), L.P. | 10% owner | 0 | — | — | 2 | −42.9% (2) | February 3, 2015 |
| Sandell Scott D and related entities | 10% owner | 0 | — | — | 2 | −29.7% (1) | December 27, 2021 |
| Baskett Forest | 10% owner | 0 | — | — | 1 | −29.7% (1) | June 12, 2020 |
| Bertrand William C Jr | Director | 1 | −40.7% (1) | 0% | 0 | — | December 21, 2015 |
| Hohenleitner Susan | Chief Financial Officer | 0 | — | — | 1 | — | February 23, 2026 |
| Korner Paul | EVP, Chief Medical Officer | 0 | — | — | 1 | −66.5% (1) | January 23, 2017 |
| Schultz Peter G | Director | 1 | −41.1% (1) | 0% | 0 | — | June 8, 2015 |
| Seeto Reginald | Chief Operating Officer | 0 | — | — | 1 | −46.6% (1) | October 26, 2017 |
When several insiders traded Ardelyx, Inc.
Months when 2 or more insiders became net buyers, or 3 or more net sellers, of Ardelyx, Inc. in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After the 3 buying crowds with six months of prices, it averaged +5.1% against the index. After 4 selling crowds, −38.5%. One company's history is too short to judge by; the test across every company is the better guide.
| Month | Crowd | 3 months on, vs S&P 500 | 6 months | 12 months |
|---|---|---|---|---|
| September 30, 2020 | 6 selling | +16.6% | +10.1% | −104.8% |
| March 31, 2017 | 3 selling | −62.8% | −63.4% | −73.2% |
| January 31, 2017 | 3 selling | +6.7% | −67.2% | −65.9% |
| July 29, 2016 | 4 buying | +23.5% | +3.6% | −67.3% |
| January 29, 2016 | 5 buying | −30.1% | −10.6% | −7.6% |
| June 30, 2015 | 5 buying | +12.4% | +22.2% | −49.7% |
| January 30, 2015 | 3 selling | −65.4% | −33.5% | −60.0% |